Biomarkers in translational research of Alzheimer's disease.
The identification and characterization of amyloid-beta (Abeta) and tau as the main pathological substrates of Alzheimer's disease (AD) have driven many efforts in search for suitable biomarkers for AD. In the last decade, research in this area has focused on developing a better understanding of the principles that govern protein deposition, mechanisms that link aggregation to toxicity and neuronal death, and a better understanding of protein dynamics in brain tissue, interstitial fluid and CSF. While Abeta and tau represent the two key pathological mediators of disease, other aspects of this multifaceted disease (e.g. oxidative stress, calcium-mediated toxicity, and neuroinflammation) are being unraveled, with the hope to develop a more comprehensive approach in exploring disease mechanisms. This has not only expanded possible areas for disease-modifying therapies, but has also allowed the introduction of novel, and potentially useful, fluid and radiological markers for the presence and progression of AD pathology. There is no doubt that the identification of several fluid and imaging biomarkers that can reliably detect the early stages of AD will have great implications in the design of clinical trials, in the selection of homogenous research populations, and in the assessment of disease outcomes. Markers with good diagnostic specificity will aid researchers in differentiating individuals with preclinical and probable AD from individuals who do not have AD pathology or have other dementing disorders. Markers that change with disease progression may offer utility in assessing the rates of disease progression and the efficacy of potential therapeutic agents on AD pathology. For both of these purposes, CSF Abeta42, amyloid imaging, and CSF tau appear to be very good markers of the presence of AD pathology as well as predictive of who will progress from MCI to AD. Volumetric MRI is also good at separating individuals with MCI and AD from controls and is predictive of who will progress from MCI to AD. Perhaps the most important role biomarkers will have, and the most needed at this time, lies in the identification of individuals who are cognitively normal, and yet have evidence of AD pathology (i.e. preclinical AD). Such individuals, it appears, can be identified with CSF Abeta42, amyloid imaging, and CSF tau. Such individuals are the most likely to benefit from future disease modifying/prevention therapies as they become available, and therefore represent the population in which the field can make the biggest therapeutic impact.
Tarawneh
Rawan
R
Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA. tarawnehr@neuro.wustl.edu
Holtzman
David M
DM
D000544:Alzheimer Disease / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000523:psychology; D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D001921:Brain / Q000378:metabolism; D006801:Humans; D057170:Translational Research, Biomedical / Q000379:methods / Q000639:trends*
D015415:Biomarkers
Ann Neurol. 2009 Aug;66(2):245-9
19743453
N Engl J Med. 2006 Dec 21;355(25):2652-63
17182990
Am J Psychiatry. 2002 May;159(5):738-45
11986126
Neurology. 2003 Nov 11;61(9):1185-90
14610118
Brain Pathol. 1999 Jan;9(1):133-46
9989456
Proteomics Clin Appl. 2007 Nov;1(11):1373-84
21136637
J Intern Med. 2004 Sep;256(3):224-34
15324365
CNS Spectr. 2008 Mar;13(3 Suppl 3):7-10
18564459
Neurology. 2002 Aug 27;59(4):627-9
12196665
Alzheimers Dement. 2008 Jan;4(1):38-48
18631949
Neurology. 1998 Oct;51(4):993-9
9781519
Arch Gen Psychiatry. 2007 Jun;64(6):718-26
17548753
Ann Neurol. 1999 Mar;45(3):358-68
10072051
Lancet Neurol. 2003 Oct;2(10):605-13
14505582
Lancet Neurol. 2006 Mar;5(3):228-34
16488378
Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S137-43
18631990
Neurology. 2003 May 13;60(9):1495-500
12743238
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8050-4
18541914
Nat Med. 2007 Nov;13(11):1359-62
17934472
Ann Neurol. 1997 Jan;41(1):17-24
9005861
Ann Neurol. 2009 May;65(5):557-68
19475670
Neurobiol Aging. 2007 Dec;28(12):1795-809
16979800
Am J Pathol. 2002 Apr;160(4):1269-78
11943712
Acta Neuropathol. 1991;82(4):239-59
1759558
J Neurol Sci. 2003 Dec 15;216(1):119-26
14607313
Biochem Biophys Res Commun. 1997 Jul 18;236(2):262-4
9240421
Neurology. 2001 Apr 10;56(7):950-6
11294935
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):11-4
15607988
EMBO Mol Med. 2009 Nov;1(8-9):371-80
20049742
Neurobiol Aging. 2000 Jan-Feb;21(1):19-26
10794844
J Comput Assist Tomogr. 2007 Jul-Aug;31(4):581-7
17882036
Neurology. 2007 Aug 14;69(7):631-9
17698783
Neurology. 2005 May 10;64(9):1520-4
15883311
Ann Neurol. 2005 Jun;57(6):896-903
15929035
J Neurosci. 2005 Aug 24;25(34):7709-17
16120771
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10966-71
11526211
Neurobiol Aging. 2009 May;30(5):682-90
17889968
PLoS One. 2009;4(1):e4183
19159013
Lancet Neurol. 2006 Aug;5(8):655-60
16857570
Science. 2009 Nov 13;326(5955):1005-7
19779148
Ann Neurol. 2006 Mar;59(3):512-9
16372280
J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):377-84
12235303
Am J Psychiatry. 2005 Apr;162(4):676-82
15800138
Ann Neurol. 2009 Apr;65(4):403-13
19296504
Neuropathol Appl Neurobiol. 1988 Jan-Feb;14(1):39-44
2453810
Neurology. 2010 Jan 19;74(3):201-9
20042704
Exp Neurol. 2000 Nov;166(1):201-3
11031097
Clin Chem. 2002 Feb;48(2):375-8
11805026
Neuroscience. 2000;95(3):721-5
10670438
J Nucl Med. 2009 Nov;50(11):1887-94
19837759
Nat Rev Neurosci. 2007 Sep;8(9):663-72
17684513
Neurobiol Aging. 2010 May;31(5):758-64
18692273
Nat Rev Neurosci. 2001 Oct;2(10):685-94
11584306
Neurology. 2005 Oct 25;65(8):1227-31
16247049
Mol Neurobiol. 2001 Aug-Dec;24(1-3):87-97
11831556
Arch Gen Psychiatry. 2004 Jan;61(1):95-102
14706948
Arch Neurol. 2002 Aug;59(8):1267-72
12164722
Neuroimage. 2005 Oct 1;27(4):934-46
15979341
Arch Med Res. 2001 Sep-Oct;32(5):367-81
11578751
J Magn Reson Imaging. 2008 Apr;27(4):685-91
18302232
Arch Neurol. 2001 Sep;58(9):1395-402
11559310
Science. 2001 Aug 24;293(5534):1491-5
11520988
Cereb Cortex. 2005 Jul;15(7):995-1001
15537673
Neurosci Lett. 2002 Nov 29;333(3):183-6
12429378
JAMA. 2003 Apr 23-30;289(16):2094-103
12709467
JAMA. 2009 Jul 22;302(4):385-93
19622817
Science. 2001 Aug 24;293(5534):1487-91
11520987
Neurology. 1991 Apr;41(4):469-78
2011242
NeuroRx. 2004 Apr;1(2):213-25
15717022
Neurology. 2007 Feb 27;68(9):666-9
17325273
Neurology. 2009 Jul 28;73(4):294-301
19636049
Neurosci Lett. 2001 Jan 19;297(3):187-90
11137759
AJNR Am J Neuroradiol. 1993 Jul-Aug;14(4):897-906
8352162
Neurobiol Aging. 2007 Jul;28(7):1070-4
16782233
Dementia. 1996 Sep-Oct;7(5):267-72
8872418
J Nucl Med. 1995 Jul;36(7):1238-48
7790950
Neurology. 2007 Feb 13;68(7):501-8
17065593
JAMA. 2001 Nov 7;286(17):2120-7
11694153
Neuroimage. 2007 Oct 15;38(1):13-24
17827035
Neurology. 2009 Oct 13;73(15):1193-9
19822868
J Neurol Sci. 2006 Dec 21;251(1-2):124-8
17097109
Neuron. 2003 Mar 27;37(6):925-37
12670422
Neurosci Lett. 1999 Jul 2;269(1):52-4
10821643
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):109-11
15608007
J Comp Neurol. 1993 Aug 8;334(2):176-91
7690048
Brain Res Brain Res Rev. 2000 Aug;33(1):95-130
10967355
J Clin Neurophysiol. 2001 Mar;18(2):178-84
11435810
J Neurol. 2008 Apr;255(4):567-74
18274807
Biol Psychiatry. 2000 Mar 15;47(6):557-61
10715362
Can J Neurol Sci. 2007 Mar;34 Suppl 1:S72-6
17469687
J Neural Transm (Vienna). 2009 Feb;116(2):203-12
19142572
J Integr Neurosci. 2007 Mar;6(1):141-74
17472227
Neurology. 2006 Aug 8;67(3):446-52
16894106
J Neurol Sci. 1998 Jun 30;158(2):134-40
9702683
Acta Neuropathol. 1988;76(6):541-9
3059748
J Clin Neurophysiol. 2005 Aug;22(4):279-84
16093901
Am J Pathol. 1999 Sep;155(3):863-8
10487843
Neurology. 1999 Apr 22;52(7):1397-403
10227624
Cell. 1993 Dec 17;75(6):1039-42
8261505
Neurobiol Aging. 2006 Mar;27(3):471-81
16213630
Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13
12764551
J Neurosci. 1996 Jul 15;16(14):4491-500
8699259
Neurology. 2007 May 15;68(20):1718-25
17502554
Arch Pathol Lab Med. 2001 Apr;125(4):510-2
11260625
Biol Psychiatry. 2010 Mar 15;67(6):584-7
19833321
Curr Alzheimer Res. 2009 Aug;6(4):347-61
19689234
Arch Neurol. 2009 May;66(5):638-45
19433664
Biol Psychiatry. 1999 Sep 15;46(6):750-5
10494442
J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9
15716518
Brain Res Brain Res Rev. 2002 Jun;39(1):29-54
12086707
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5856-61
11296263
Neuroscience. 2006 Dec;143(3):793-803
17049178
Neurology. 2009 Jul 28;73(4):287-93
19636048
Ann N Y Acad Sci. 2007 Feb;1097:114-45
17413016
Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):6-15
16493230
Clin Chem. 2008 Oct;54(10):1617-23
18703769
J Neurosci Res. 2003 May 15;72(4):520-6
12704813
J Neurochem. 1999 Feb;72(2):771-6
9930752
Neurology. 2004 Feb 10;62(3):433-8
14872026
Neuroimage. 2001 Aug;14(2):298-309
11467904
Neuron. 2005 Dec 22;48(6):913-22
16364896
Brain. 2004 Apr;127(Pt 4):811-24
14985261
Neurology. 2004 Mar 23;62(6):925-31
15037694
Brain. 2006 Nov;129(Pt 11):2856-66
16854944
Neurobiol Aging. 1997 Jul-Aug;18(4):377-9; discussion 389-92
9330965
Neurobiol Aging. 1998 Sep-Oct;19(5):401-5
9880042
Neuron. 2009 Jul 30;63(2):178-88
19640477
Neurobiol Aging. 2001 May-Jun;22(3):351-2
11378238
Arch Neurol. 2007 Mar;64(3):343-9
17210801
Ann Neurol. 2004 Mar;55(3):306-19
14991808
Arch Neurol. 2002 Nov;59(11):1729-34
12433260